Nurix Therapeutics, Inc. Common stock NRIX
$23.67
+6.96%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | FORM 4 | 2026-10-14 | View → |
| 10-Q | 10-Q | 2026-10-13 | View → |
| 8-K | 8-K | 2026-10-13 | View → |
| 4 | FORM 4 | 2026-10-02 | View → |
| 4 | FORM 4 | 2026-09-02 | View → |
| 4 | FORM 4 | 2026-09-01 | View → |
| 4 | FORM 4 | 2026-08-05 | View → |
| 4 | FORM 4 | 2026-08-05 | View → |
| 4 | FORM 4 | 2026-08-04 | View → |
| 4 | FORM 4 | 2026-08-03 | View → |
| 4 | FORM 4 | 2026-07-30 | View → |
| 4 | FORM 4 | 2026-07-30 | View → |
| 4 | FORM 4 | 2026-07-30 | View → |
| 10-Q | 10-Q | 2026-07-09 | View → |
| 8-K | 8-K | 2026-07-09 | View → |
| 4 | FORM 4 | 2026-07-02 | View → |
| 4 | FORM 4 | 2026-06-25 | View → |
| 4 | FORM 4 | 2026-06-25 | View → |
| 8-K | 8-K | 2026-06-11 | View → |
| 8-K | 8-K | 2026-06-08 | View → |
| 4 | FORM 4 | 2026-06-02 | View → |
| 4 | FORM 4 | 2026-05-15 | View → |
| 4 | FORM 4 | 2026-05-15 | View → |
| 4 | FORM 4 | 2026-05-15 | View → |
| 4 | FORM 4 | 2026-05-15 | View → |
| 4 | FORM 4 | 2026-05-15 | View → |
| 4 | FORM 4 | 2026-05-15 | View → |
| 4 | FORM 4 | 2026-05-15 | View → |
| 4 | FORM 4 | 2026-05-15 | View → |
| 8-K | 8-K | 2026-05-15 | View → |
| 4 | FORM 4 | 2026-05-05 | View → |
| 4 | FORM 4 | 2026-05-04 | View → |
| 4 | FORM 4 | 2026-05-01 | View → |
| 4 | FORM 4 | 2026-04-30 | View → |
| 4 | FORM 4 | 2026-04-30 | View → |
| 4 | FORM 4 | 2026-04-30 | View → |
| 10-Q | 10-Q | 2026-04-08 | View → |
| 8-K | 8-K | 2026-04-08 | View → |
| 4 | FORM 4 | 2026-04-02 | View → |
| DEF 14A | DEF 14A | 2026-03-27 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $23.67
- Market Cap
- $2.42 billion
- 52-Week Range
- $8.20 – $28.23
- Average Volume
- 1.75 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.